Stay updated with breaking news from Program On Medicare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.
About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.
About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy.